| Overview |
| bsm-90168r-50µL |
| Atg16L1 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ATG16L1 |
| 1-150/607 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 55054 |
| Q676U5 |
| ATG16L1; Autophagy Related 16 Like 1; ATG16A; APG16L; WDR30; Autophagy-Related Protein 16-1; FLJ10035; ATG16L; ATG16 Autophagy Related 16-Like 1 (S. Cerevisiae); ATG16 Autophagy Related 16-Like (S. Cerevisiae); APG16 Autophagy 16-Like (S. Cerevisiae); ATG16 Autophagy Related 16-Like 1; WD Repeat Domain 30; APG16-Like 1; APG16L Beta; IBD104C Cysteine Peptidase; ATG4 Autophagy Related 4 Homolog C; AUT-Like 1 Cysteine; Endopeptidase; APG4 Autophagy 4 Homolog C; EC 3.4.22.-; EC 3.4.22; APG4-C |
| Cell Line: 293T Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |